• Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised

  • Mar 10 2025
  • Duración: 21 m
  • Podcast

Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss treatment strategies for people who have severe COVID-19, including:

    • Antiviral therapy with remdesivir
    • Dexamethasone and other systemic corticosteroids
    • Immunomodulators, such as JAK inhibitors or IL-6 inhibitors
    • Overviews of clinical trial data demonstrating how and when to use these therapies


    Presenters:

    Stephen Cantrill, MD, FACEP​
    Associate Director and Medical Director (Retired) ​
    Department of Emergency Medicine​
    Denver Health Medical Center​
    Associate Professor ​
    Department of Emergency Medicine​
    University of Colorado Health Sciences Center​
    Denver, Colorado

    Rajesh T. Gandhi, MD​
    Massachusetts General Hospital​
    Professor of Medicine​
    Harvard Medical School​
    Boston, Massachusetts

    Payal K. Patel, MD, MPH, FIDSA​
    Systemwide Director of Antimicrobial Stewardship​
    Associate Professor, Division of Infectious Diseases​
    Intermountain Health​
    Salt Lake City, Utah

    Link to full program:
    https://bit.ly/4gu2gcU

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Treatment Options for Severe COVID-19 in Patients Who Are Immunocompromised

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles